Table 1. Demographic Characteristics and Clinical Data.

From: Association between Sarcopenic Obesity and Changes in Skeletal Muscle Mass and Quality in Patients with Stroke Who Undergo Convalescent Rehabilitation

Overall Group with sarcopenic obesity Group without sarcopenic obesity p Value
(N = 173) (n = 8) (n = 165)
On admission
Age, years 67 [59-71] 69 [66-70] 66 [59-71] 0.597
Sex, n (%) 0.264
Male 108 (62) 3 (37) 105 (64)
Female 65 (38) 5 (63) 60 (36)
Stroke type, n (%) 0.286
Brain infarction 104 (60) 4 (50) 100 (61)
Brain hemorrhage 49 (28) 4 (50) 45 (27)
Subarachnoid hemorrhage 20 (12) 0 (0) 20 (12)
Sarcopenia, n (%) 106 (61) 8 (100) 98 (59) 0.055
Obesity, n (%) 61 (35) 8 (100) 53 (32) <0.001
NIHSS score, points 3 [1-5] 5 [4-5] 3 [1-5] 0.166
MNA-SF score, points 8 [7-10] 9 [7-10] 8 [7-10] 0.070
PhA, degrees 4.5 [3.9-5.0] 4.1 [4.0-4.2] 4.5 [3.9-5.1] 0.120
Days from onset to admission to rehabilitation wards, days 17 [11-27] 23 [15-26] 17 [11-27] 0.445
At discharge
Length of hospital stay, days 64 [39-104] 67.5 [33.2-86.0] 64 [40-105] 0.742
Protein intake, g/kg/day 1.1 [1.0-1.2] 1.0 [1.0-1.1] 1.1 [1.0-1.2] 0.366
Energy intake, kcal/kg/day 29.6 [23.5-37.2] 22.8 [19.7-28.4] 30.4 [24.3-37.4] 0.012
Rehabilitation volume, min/day 143.4 [131.8-158.1] 144.5 [127.4-159.2] 143.4 [132.1-158.1] 0.977
SMM, kg/BMI 0.745 [0.597-0.853] 0.400 [0.367-0.553] 0.755 [0.611-0.859] <0.001
PhA, degrees 4.6 [4.0-5.2] 4.1 [3.8-4.2] 4.7 [4.1-5.2] 0.013
Changes in SMM, kg/BMI 0.021 ± 0.030 − 0.003 ± 0.011 0.022 ± 0.030 0.022
Changes in PhA, degrees 0.1 ± 0.3 − 0.1 ± 0.3 0.1 ± 0.3 0.011
Table 2. Baseline Characteristics of Sarcopenic Obesity Diagnosis in Japan.

From: Association between Sarcopenic Obesity and Changes in Skeletal Muscle Mass and Quality in Patients with Stroke Who Undergo Convalescent Rehabilitation

Overall Sarcopenic obesity group No sarcopenic obesity group p Value
(N = 173) (n = 8) (n = 165)
Screening for sarcopenia
 Calf circumference, cm 32.5 [30.0-35.5] 30.5 [25.9-31.7] 32.5 [30.0-35.6] 0.031
Screening for obesity
 BMI, kg/m2 23.2 [21.1-27.0] 26.9 [26.6-28.9] 23.1 [21.0-27.0] 0.007
Evaluation of sarcopenia
 Hand grip, kg 24.4 [18.0-32.9] 14.3 [12.0-16.4] 25.4 [18.4-33.4] 0.002
 SMM, kg/BMI 0.719 [0.567-0.836] 0.405 [0.373-0.557] 0.731 [0.588-0.836] 0.002
Evaluation of obesity
 Body fat percentage, % 29.7 [23.4-38.1] 48.4 [42.7-51.3] 29.5 [23.4-36.5] <0.001
Table 3. Multiple Regression Analysis with Changes in SMM and PhA.

From: Association between Sarcopenic Obesity and Changes in Skeletal Muscle Mass and Quality in Patients with Stroke Who Undergo Convalescent Rehabilitation

Changes in SMM Changes in PhA
β (95% CI) p Value VIF β (95% CI) p Value VIF
Sarcopenic obesitya −0.281 (−0.449 to −0.113) <0.001 1.44 −0.189 (−0.367 to −0.010) 0.038 1.44
Sarcopeniab 0.164 (−0.038 to 0.366) 0.111 2.08 0.058 (−0.156 to 0.272) 0.593 2.08
Obesityc 0.264 (0.060 to 0.468) 0.120 2.12 0.012 (−0.204 to 0.228) 0.913 2.12
Age 0.015 (−0.140 to 0.170) 0.852 1.22 0.107 (−0.058 to 0.271) 0.202 1.22
Sexd −0.102 (−0.273 to 0.070) 0.244 1.50 −0.146 (−0.328 to 0.035) 0.114 1.51
NIHSS score on admission −0.015 (−0.172 to 0.142) 0.852 1.25 0.006 (−0.160 to 0.172) 0.945 1.25
MNA-SF score on admission −0.028 (−0.189 to 0.133) 0.732 1.33 −0.060 (−0.231 to 0.111) 0.490 1.32
Length of hospital stay 0.320 (0.157-0.484) < 0.001 1.36 0.040 (−0.133 to 0.213) 0.646 1.36
Protein intake −0.085 (−0.227 to 0.057) 0.241 1.03 −0.032 (−0.183 to 0.118) 0.674 1.03
Energy intake −0.076 (−0.270 to −0.119) 0.444 1.93 0.008 (−0.198 to 0.214) 0.941 1.93
Rehabilitation volume 0.078 (−0.064 to 0.220) 0.281 1.03 −0.011 (−0.162 to 0.139) 0.885 1.02
PAGE TOP